Journals / Turkish Journal of Gastroenterology / 2018 / Cilt: 29 - Sayı: 5

Can pancreatic steatosis affect exocrine functions of pancreas?

Pages
588–594
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There were no significant differ-ences in terms of severity or the anatomic distribution of PS in patients with PS with EPI based on MRI (p=0.052, p=0.198, p=0.405) Conclusion: Current study demonstrates that PS can cause EPI.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: Pancreatic steatosis (PS) is a generally used term to define accumulation of fat in the pancreas.
📊
Key Findings & Data:Materials and Methods: Forty-three patients with PS determined by 3 tesla magnetic resonance imaging (MRI) and 48 patients without PS were included in this study.
💡
Conclusion & Impact:There were no significant differ-ences in terms of severity or the anatomic distribution of PS in patients with PS with EPI based on MRI (p=0.052, p=0.198, p=0.405) Conclusion: Current study demonstrates that PS can cause EPI.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background/Aims: Pancreatic steatosis (PS) is a generally used term to define accumulation of fat in the pancreas. In theory PS may be able to affect the exocrine function of pancreas. In this study we aimed to determine the effect of PS on exocrine pancreas function. Materials and Methods: Forty-three patients with PS determined by 3 tesla magnetic resonance imaging (MRI) and 48 patients without PS were included in this study. Patients with PS were classified as group 1 and control patients were classified as group 2. Fecal elas-tase-1 levels were determined. Fecal elastase-1 levels <200 μg/g were defined as exocrine pancreatic insufficiency (EPI). Patients with PS were further grouped according to severity and anatomic distribution of steatosis based on findings of 3 tesla MRI. Results: Fecal elastase-1 levels was significantly lower in group 1 compared to group 2 (319.76±45.7 vs 549.31±69.4, respectively, p=0.003). Proportion of patients with EPI was significantly higher in group 1 than group 2 (35.5% vs 12% p=0.042). There were no significant differ-ences in terms of severity or the anatomic distribution of PS in patients with PS with EPI based on MRI (p=0.052, p=0.198, p=0.405) Conclusion: Current study demonstrates that PS can cause EPI.

🔖

Cite This Article

TAHTACI, M., ALGIN, O., KARAKAN, T., YÜREKLİ, Ö. T., ALIŞIK, M., KÖSEOĞLU, H., METİN, M. R., BOLAT, A. D., EREL, Ö., ERSOY, O. (2018). Can pancreatic steatosis affect exocrine functions of pancreas?. Turkish Journal of Gastroenterology, Cilt: 29 - Sayı: 5, 588–594. https://ajindex.com/articles/410072

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Van Herpen NA, Schrauwen-Hinderling VB. Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol Behav 2008
  2. [CrossRef] Schaefer JH. The normal weight of the pancreas in the adult hu- man being: a biometric study. Anat Rec 1926
  3. [CrossRef] Smits MM, van Geenen EJ. The clinical significance of pancreatic steatosis.Nat Rev Gastroenterol Hepatol 2011
  4. [CrossRef] Saisho Y, Butler AE, Meier JJ, et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat 2007
  5. [CrossRef] Lingvay I, Esser V, Legendre JL, et al. Noninvasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab 2009
  6. [CrossRef] Sasaki M, Nakanuma Y, Ando H.Lipomatous pseudohypertrophy of the pancreas in a patient with cirrhosis due to chronic hepatitis B.Pathol Int 1998
  7. [CrossRef] Tham RT, Heyerman HG, Falke TH, et al. Cystic fibrosis: MR imag- ing of the pancreas. Radiology 1991
  8. [CrossRef] Cubuk M, Arslan G, Ceken K, et al. Schwachman-Diamond syn- drome. A case report. Acta Radiol 2000
  9. [CrossRef] Tariq H, Nayudu S, Akella S, et al. Non-Alcoholic Fatty Pancreatic Disease: A Review of Literature. Gastroenterology Res 2016
  10. [CrossRef] Carter R, Mouralidarane A, Soeda J, et al. Non-alcoholic fatty pancreas disease pathogenesis: a role for developmental program- ming and altered circadian rhythms. PLoS One 2014
  11. e89505. [CrossRef] Begovatz P, Koliaki C, Weber K, et al. Pancreatic adipose tissue infiltration, parenchymal steatosis and beta cell function in humans. Diabetologia 2015
  12. [CrossRef] Keller J, Layer P.Human pancreatic exocrine response to nutri- ents in health and disease. Gut 2005
  13. 54(Suppl 6): vi1-28. [CrossRef] Pezzilli R, Andriulli A, Bassi C, et al. Exocrine pancreatic insuffi- ciency in adults: a shared position statement of the Italian Associ- ation for the Study of the Pancreas. World J Gastroenterol 2013
  14. [CrossRef] Catanzaro R, Cuffari B, Italia A, et al. Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease. World J Gastroen- terol 2016
  15. [CrossRef] Aubert A, Gornet JM, Hammel P, et al. Diffuse primary fat replace- ment of the pancreas: an unusual cause of steatorrhea. Gastroen- terol Clin Biol 2007
  16. [CrossRef] Ambesh P, Lal H. Pancreatic lipomatosis: Complete replacement of pancreas by fat. J Clin Diagn Res